c.nyberg
TL2 · Kumasi
Contributes reviews on supplier material. Based in Kumasi.
Joined 9 March 2025 · last posted 20d
84 posts, newest first. Showing up to 150.
-
How much context is too much context in a first post? Replied, post #44 · Start Here › How to Ask · 8 Jul 2026 · 0 likes It is fine to say you cannot explain why you are asking. Nobody will press, and the technical part of the question can usually be answered without the context. Adding a…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #84 · Practice › Storage & stability · 7 Jul 2026 · 2 likes Post #82 and I disagree about the size of the effect, not about the direction. Small methodological point on peptide: repeating a measurement is cheap and resolves most…
-
Insurance and replacement policies, compared Replied, post #65 · Sourcing › Logistics · 5 Jul 2026 · 11 likes Adding the measurement that post #64 says would settle it. The version of insurance and replacement policies that I was taught turned out to be a teaching…
-
Naming conventions for research peptides and the confusion they cause Replied, post #20 · Compounds › Other compounds · 24 Jun 2026 · 4 likes Adding a data point of agreement rather than a data point.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #128 · Practice › Interactions · 18 Jun 2026 · 0 likes Narrowing post #125, because the general version has more than one answer. Two people in this thread mean different things by Metformin co-administration and are…
-
Official shortage notices and what they authorise Replied, post #113 · Access › Shortages · 18 Jun 2026 · 0 likes Reports that a pharmacy has stock are the least durable information on the site and are still worth posting with a date. It is one reading of the data and not the only…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #43 · Analytics › Method validation · 5 Jun 2026 · 14 likes An independent laboratory's method being different from the supplier's is not a discrepancy. It becomes one only when the results differ by more than both methods'…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #45 · Sourcing › Red flags · 4 Jun 2026 · 11 likes Prices well below the rest of the market are a fact rather than a finding. They are worth noting and they do not establish anything on their own. A weak preference…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #48 · Compounds › Semaglutide · 2 Jun 2026 · 30 likes Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the reason for the long half-life and it is also the reason…
-
Books and papers worth reading that are not about this at all — one year on Replied, post #4 · Lounge › Off topic · 28 May 2026 · 13 likes Digression worth the space: the archive is starting to be genuinely long. There are questions here whose good answer is four years old and still correct, and that only…
-
Tracking intake honestly when appetite is absent Replied, post #38 · Nutrition & Training › Protein & intake · 27 May 2026 · 14 likes Confirming post #37 from a second method, which matters more than confirming it from a second person. Fibre: adequate fibre intake supports fullness and gut motility,…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #10 · Compounds › Secretagogues & GH axis · 23 May 2026 · 9 likes Worth separating two things that post #8 runs together. Adding a null result on GHRH analogues versus ghrelin mimetics. I looked, carefully, and found nothing, and null…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #26 · Analytics › Home & field testing · 20 May 2026 · 18 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
Constipation management, with a dietitian's contribution Replied, post #65 · Practice › Side effects · 14 May 2026 · 0 likes Constipation management is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
-
Step therapy requirements and how to satisfy them Replied, post #17 · Access › Insurance & coverage · 13 May 2026 · 17 likes Keep every document with dates in one place. An appeal months later is assembled from whatever you kept. Not the whole picture, but the part of it I can speak to.
-
Five questions in one post gets you one answer — how to split them Replied, post #70 · Start Here › How to Ask · 2 May 2026 · 12 likes Edit the first post rather than adding the missing detail in reply nine. People arriving later read the first post and stop. Second-hand, so weight it accordingly.
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #12 · Analytics › Home & field testing · 1 May 2026 · 12 likes Before the thread moves on from Lateral-flow and colorimetric approaches — what is the sample size behind the claim? I am not being difficult; I have seen the same…
-
Shakes versus food: a pragmatic assessment Replied, post #7 · Nutrition & Training › Protein & intake · 1 May 2026 · 5 likes Renal considerations around higher protein intake apply to people with existing renal impairment and are frequently generalised beyond that population. Not the answer,…
-
Journal club: is percentage weight change the right endpoint? Replied, post #109 · Evidence › Journal club · 27 Apr 2026 · 29 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
[2026 update] What a purity-only report leaves out Replied, post #94 · Sourcing › Independent verification · 17 Apr 2026 · 9 likes What I would want before treating purity-only as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually…
-
Grapefruit: why this class is not the class that cares Replied, post #128 · Practice › Interactions · 6 Apr 2026 · 0 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #34 · Data & Tools › Calculators · 5 Apr 2026 · 7 likes Answering the question post #32 raises rather than the one it answers. Mass error checking: enter your observed mass and theoretical mass and check whether the…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #60 · Start Here › Welcome · 31 Mar 2026 · 16 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Second pass at: Submitting a sample: the process end to end Replied, post #13 · Sourcing › Independent verification · 12 Mar 2026 · 5 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Transporting a vial for a weekend away — a second dataset Replied, post #2 · Practice › Storage & stability · 4 Mar 2026 · 6 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Getting a referral rather than a refusal Replied, post #8 · Clinical › Prescriber conversations · 3 Mar 2026 · 0 likes Picking up post #7: that is the part I would want checked first. Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #142 · Sourcing › Independent verification · 28 Feb 2026 · 33 likes A supplier's own certificate is not independent. It can be posted, it is useful, and it is labelled for what it is.
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #92 · Evidence › Study critique · 27 Feb 2026 · 1 like Understood. Thank you for being specific about the limits of it.
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #41 · Research Methods › Statistics · 27 Feb 2026 · 2 likes Regression to the mean: if you select people with extreme values (very high or very low), their next measurement is often less extreme just by chance. This can look…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #77 · Practice › Dosing & titration · 19 Feb 2026 · 5 likes The four-week step is a trial convention, not a pharmacological constant. It is roughly four half-lives for a week-long half-life, which is the interval at which you…
-
Clearance pathways and what renal impairment changes Replied, post #8 · Pharmacology › Pharmacokinetics · 10 Feb 2026 · 12 likes The useful distinction on clearance pathways is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error…
-
Journal club: PIONEER 6 as a safety trial Replied, post #16 · Evidence › Journal club · 6 Feb 2026 · 18 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
-
About the Calculators category Replied, post #5 · Data & Tools › Calculators · 31 Jan 2026 · 3 likes Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors that come from forgetting units. Always verify units in and out.…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #73 · Clinical › Special populations · 25 Jan 2026 · 0 likes Checked the Pregnancy and pregnancy planning claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the…
-
What to include when your question involves a chromatogram Replied, post #17 · Start Here › How to Ask · 3 Jan 2026 · 7 likes Thank you for the correction. I would rather find out here than later.
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #38 · Compounds › Retatrutide · 31 Dec 2025 · 3 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #27 · Practice › Side effects · 21 Dec 2025 · 3 likes On post #23 — agreed on the reasoning, with one qualification. The documentation on Dizziness on standing is better than this thread and I say that as someone who has…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #7 · Documentation › Wiki requests · 21 Dec 2025 · 12 likes Documents that are mostly a worked example age better than documents that are mostly a summary, because the arithmetic does not change.
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #33 · Compounds › Other compounds · 7 Dec 2025 · 0 likes Good question, well framed, and I would like to see it answered properly.
-
DXA precision and the least significant change for lean mass Replied, post #41 · Outcomes › Body composition · 4 Dec 2025 · 0 likes Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent. Useful as a supplementary measure but not as a primary…
-
Absolute versus relative contraindications Replied, post #9 · Safety › Contraindications · 2 Dec 2025 · 12 likes Narrowing post #6, because the general version has more than one answer. Interaction-based contraindications are compound-pair specific and are the ones most often…
-
Oral versus injectable exposure: comparing apples to a different fruit Replied, post #12 · Compounds › Oral incretins · 14 Nov 2025 · 15 likes PIONEER 6 is the cardiovascular outcome trial for oral semaglutide and it enrolled a diabetes population at high cardiovascular risk. Quoting it outside that population…
-
A comparison of home results against a laboratory result on the same vial Replied, post #61 · Analytics › Home & field testing · 10 Nov 2025 · 32 likes The right question for any home test is: what physical quantity does it measure, and what would have to be true for that quantity to answer your question? Most…
-
New subcategory: rationale and scope Replied, post #112 · Meta › Announcements · 24 Oct 2025 · 22 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope. Correct me on the arithmetic if it…
-
Payment mechanics and the recovery options that do not exist Replied, post #51 · Sourcing › Payments · 21 Oct 2025 · 6 likes Ask what happens if the material fails independent testing before you order, not afterwards. The answer is informative and costs one email.
-
Pinch or no pinch, and how needle length changes the answer Replied, post #111 · Practice › Administration · 15 Oct 2025 · 0 likes Source for the pinch figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the paper…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #16 · Safety › Adverse events · 13 Oct 2025 · 13 likes Adding the measurement that post #15 says would settle it. Where to report: in many countries there is a pharmacovigilance system where adverse events can be reported.…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #95 · Practice › Administration · 5 Oct 2025 · 0 likes Picking up post #94: that is the part I would want checked first. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated…
-
Documentation that materially improves an appeal's chances Replied, post #18 · Access › Insurance & coverage · 4 Oct 2025 · 14 likes I would put moderate confidence on the mainstream reading of documentation and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
-
When to stop reading forums, including this one Replied, post #25 · Wellbeing › Mental health · 13 Sep 2025 · 9 likes Thank you — that answers what I came here to find out.
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #52 · Sourcing › Vendor reports · 7 Sep 2025 · 2 likes The version of vendor documentation pages that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #86 · Evidence › Trials · 4 Sep 2025 · 12 likes Composite endpoints should be read component by component. A composite driven entirely by its softest component is a different finding from one where the components…
-
Research-use-only labelling: what it means and what it does not Replied, post #23 · Sourcing › Regulatory · 18 Aug 2025 · 13 likes Narrowing post #22, because the general version has more than one answer. My understanding of research-use-only labelling is a few years old and may have been…
-
Column chemistry choices for a 40-residue peptide Replied, post #14 · Analytics › HPLC & UHPLC · 16 Aug 2025 · 31 likes Two things can be true about column chemistry choices at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here…
-
A request that was declined, and the reasoning — a second dataset Replied, post #69 · Documentation › Wiki requests · 13 Aug 2025 · 24 likes Where I part company with post #65, and it is a narrow parting. Suggesting content for a page: if you know a maintained page is missing something important, post a…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #3 · Evidence › Journal club · 8 Aug 2025 · 3 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
-
About the Logistics category Replied, post #6 · Sourcing › Logistics · 5 Aug 2025 · 14 likes The most useful logistics record is boring: order date, dispatch date, arrival date, condition on arrival. Four fields, and they answer most questions here.
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #3 · Data & Tools › Datasets · 19 Jul 2025 · 6 likes Practical experience of community side-effect dataset, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what…
-
A field-by-field walk through a certificate of analysis Replied, post #66 · Analytics › COA interpretation · 16 Jul 2025 · 0 likes Worth separating two things that post #64 runs together. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #10 · Compounds › Cagrilintide & amylin analogues · 5 Jul 2025 · 1 like Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #33 · Devices › Syringes & needles · 3 Jul 2025 · 12 likes Offering a way to settle Filter needles rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the…
-
Comparing my trajectory with the trial curves, carefully Replied, post #15 · Outcomes › Progress reports · 18 Jun 2025 · 0 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #43 · Compounds › Other compounds · 16 Apr 2025 · 12 likes Coming back to post #40, because the follow-up matters more than the original answer. A compound with no established assay is a compound where a certificate can say…
-
A certificate with no method stated: what can you conclude? Replied, post #8 · Analytics › COA interpretation · 30 Mar 2025 · 17 likes Taking post #5 at face value and following it one step further. The distinction between release testing and characterisation is one industrial documents make and retail…
-
Preservatives: function, testing, and limits Replied, post #22 · Pharmacology › Formulation chemistry · 20 Mar 2025 · 11 likes Sterility and stability are separate properties requiring separate controls. A preservative addresses one of them and nothing about the other. One more caveat and then…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #110 · Pharmacology › Receptor biology · 16 Mar 2025 · 17 likes Picking up post #109: that is the part I would want checked first. Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #3 · Clinical › Comorbidities · 16 Mar 2025 · 0 likes On the opening post — agreed on the reasoning, with one qualification. The honest answer to most questions here is that the trial population did not include the case…
-
Charge states for a 4 kDa peptide, worked through Replied, post #106 · Analytics › Mass spectrometry · 14 Mar 2025 · 32 likes Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈ 1371, quadruply at ≈ 1029. Those are the positions…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #68 · Pharmacology › Receptor biology · 9 Mar 2025 · 15 likes Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #66 · Compounds › Secretagogues & GH axis · 3 Feb 2025 · 21 likes I read post #62 twice before replying, because I had assumed the opposite. Two claims get bundled together under well-designed human trial and they need separating. The…
-
Levothyroxine timing: a real interaction with a simple fix Replied, post #23 · Practice › Interactions · 20 Jan 2025 · 1 like The confident answers on levothyroxine timing and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
-
Oxidation pathways for methionine and tryptophan Replied, post #49 · Analytics › Impurities & related substances · 30 Dec 2024 · 24 likes The arithmetic in post #47 is right; the assumption feeding it is the part to check. The honest answer on oxidation pathways for methionine is that it depends, and the…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #30 · Compounds › Semaglutide · 23 Dec 2024 · 3 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #16 · Evidence › Journal club · 21 Dec 2024 · 11 likes Post #14 describes the usual case. This is about the unusual one. The baseline characteristics table is the single most useful page for the questions that get asked…
-
Coming back to: When to suspect the method rather than the sample Replied, post #57 · Analytics › Method validation · 11 Dec 2024 · 32 likes Range and working range are different things and a certificate rarely distinguishes them. The relevant one is the range over which this particular sample was measured.…
-
Transit times by route, from a logged dataset — the long version Replied, post #33 · Sourcing › Logistics · 26 Nov 2024 · 15 likes I read post #31 twice before replying, because I had assumed the opposite. Peak periods and public holidays affect this more than any other factor and are entirely…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #10 · Practice › Reconstitution · 10 Nov 2024 · 0 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #128 · Clinical › Bloodwork · 20 Oct 2024 · 7 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason.
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #12 · Clinical › Comorbidities · 9 Oct 2024 · 10 likes Reframing Hypertension improvement slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #20 · Analytics › Method validation · 23 Aug 2024 · 19 likes I read post #17 twice before replying, because I had assumed the opposite. What I would want before treating stability-indicating method as settled: the method, the…
-
Follow-up: A partial dose because the pen emptied mid-injection Replied, post #9 · Practice › Administration · 28 Jul 2024 · 3 likes Adding a data point of agreement rather than a data point.
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #4 · Analytics › COA interpretation · 11 Jul 2024 · 8 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Journal club: FLOW and the renal composite, component by component Replied, post #17 · Evidence › Journal club · 10 Jul 2024 · 0 likes I had written a reply contradicting post #15 and deleted it. Here is what survived. Where the group cannot agree, record the disagreement rather than resolving it by…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #4 · Clinical › Prescriber conversations · 8 Jun 2024 · 19 likes On post #2 — agreed on the reasoning, with one qualification. Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be…